Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on investment.

The trailing-twelve-month return on investment at Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is 120.50 percent. Nymox Pharmaceutical's revenue for the same period is $2.90 million.

The trailing-twelve-month return on investment at Quotient Ltd (NASDAQ: QTNT) is 66.70 percent. Quotient's gross margin for the same period is 50.50 percent.

The trailing-twelve-month return on investment at Meridian Bioscience, Inc. (NASDAQ: VIVO) is 21.70 percent. Meridian Bioscience's PEG ratio is 1.36.

The trailing-twelve-month return on investment at AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is 15.60 percent. AMAG Pharmaceuticals' EPS for the same period is $4.40.